{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:09:46Z","timestamp":1769353786805,"version":"3.49.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Prolonged corticosteroid therapy may result in hypothalamic-pituitary-adrenal (HPA) axis suppression and subsequent adrenal insufficiency (AI). The short Synacthen stimulation test (SST) remains the gold standard for assessing adrenal function, yet morning serum cortisol (MSC) may serve as a valuable screening tool during corticosteroid withdrawal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the diagnostic performance of MSC in predicting SST outcomes during glucocorticoid withdrawal and to compare the results of high-dose (HDT) versus low-dose (LDT) Synacthen stimulation protocols. Methods: This retrospective analysis examined 164 SSTs performed between 2006-2021 in patients undergoing prednisone withdrawal assessment. LDT (1 \u00b5g Synacthen) was utilized from 2006-2010, followed by HDT (250 \u00b5g Synacthen) from 2010-2021. Receiver operating characteristic (ROC) analysis was employed to determine optimal MSC thresholds for predicting adequate adrenal response, defined as cortisol \u226518 \u00b5g\/dL (500 nmol\/L) at 30 minutes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No significant differences were observed between LDT and HDT protocols regarding stimulated cortisol levels or test outcomes. ROC analysis revealed optimal MSC thresholds of 10.4 \u00b5g\/dL (287 nmol\/L) for LDT and 11.2 \u00b5g\/dL (309 nmol\/L) for HDT. In the entire cohort, MSC threshold of 10.9 \u00b5g\/dL (301 nmol\/L) demonstrated balanced sensitivity (70%) and specificity (85.5%). Notably, among patients with MSC levels between 10-15 \u00b5g\/dL (276-414 nmol\/L), and 10-12 \u00b5g\/dL (276-331 nmol\/L), 40% and 48% failed the SST, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>No significant differences were observed between LDT and HDT protocols regarding stimulated cortisol levels or test outcomes, and MSC provides valuable adjunctive information for assessing HPA axis recovery. However, a substantial proportion of patients with MSC near the recommended discontinuation threshold of 10 \u00b5g\/dL (300 nmol\/L) still demonstrate abnormal SST responses.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1655146","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T04:10:55Z","timestamp":1759723855000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Morning serum cortisol as a predictor of synacthen stimulation test outcomes during corticosteroid withdrawal: a comparative analysis of high-dose and low-dose protocols"],"prefix":"10.3389","volume":"16","author":[{"given":"Leonard","family":"Saiegh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balsam","family":"Dakwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katya","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilana","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muaweya","family":"Mahamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Sheikh Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"Fardet","year":"2011","journal-title":"Rheumatol (Oxford)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: Systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1807486","article-title":"Adrenal crisis","volume":"381","author":"Rushworth","year":"2019","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00252-7","article-title":"Adrenal insufficiency","volume":"7","author":"Hahner","year":"2021","journal-title":"Nat Rev Dis Prim 2021\u201371"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e3282fdf16d","article-title":"Low-dose and high-dose adrenocorticotropin testing: Indications and shortcomings","volume":"15","author":"Dickstein","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1700","article-title":"ACTH stimulation tests for the diagnosis of adrenal insufficiency: Systematic review and meta-analysis","volume":"101","author":"Ospina","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae250","article-title":"European society of endocrinology and endocrine society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency","volume":"109","author":"Beuschlein","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1390575","article-title":"The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary-adrenal function","volume":"139","author":"Ambrosi","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-4-773","article-title":"Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test","volume":"72","author":"Dickstein","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0710","article-title":"Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: A metaanalysis","volume":"93","author":"Kazlauskaite","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12020-017-1330-5","article-title":"Performance of low-dose cosyntropin stimulation test handled via plastic tube","volume":"57","author":"Saiegh","year":"2017","journal-title":"Endocrine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14405","article-title":"Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatment","volume":"94","author":"Sagar","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13232","article-title":"Baseline morning cortisol level as a predictor of pituitary\u2013adrenal reserve: a comparison across three assays","volume":"86","author":"Sbardella","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200182","article-title":"Home waking salivary cortisone to screen for adrenal insufficiency","volume":"2","author":"Debono","year":"2023","journal-title":"NEJM Evid"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13803","article-title":"Extensive clinical experience: Hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess","volume":"89","author":"Hurtado","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-019-0105-4","article-title":"The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: A retrospective cohort study","volume":"4","author":"Costello","year":"2020","journal-title":"BMC Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: A cohort study","volume":"8","author":"Jamilloux","year":"2013","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.03.001","article-title":"Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review","volume":"46","author":"Joseph","year":"2016","journal-title":"Semin Arthritis Rheum"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1655146\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T04:10:55Z","timestamp":1759723855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1655146\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":19,"alternative-id":["10.3389\/fendo.2025.1655146"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1655146","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"article-number":"1655146"}}